Clinical Trial Update: V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concomitant administration of V260 rotavirus vaccine with INFANRIX Hexa in healthy infants; the study has completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Disease

Drugs mentioned

• Infanrix Hexa (DTPa-HBV-IPV/Hib)
• V260

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-09-23